Skip to main content
Signal8

CERO THERAPEUTICS HOLDINGS, INC. (CERO)

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc.

OTC:CEROHealthcare
-4.17%$0.0046
Mkt Cap$383K
EV-
Float–
O/S83.31M
VOL105K sh
$ Vol$463
RVOL0.28×
Inst Own-
Net Cash/Sh-
EarningsDec 2 · in 2w
Dilution
Short interest (FINRA)
Not computed: short interest % needs a single float figure, and the float on record is a bound or estimate.
Oct 30 (18d)
20.2K
Oct 30 (18d)prev 1.0K▲ 1911.5%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow CERO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
70.4%
Nov 16 (1d)prev 66.0%▲ 4.4 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

977
Sep 23 (55d)prev 989▼ 1.2%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202620.2K sh
Oct 15, 20261.0K sh
Sep 30, 202612.4K sh
Sep 15, 20262.5K sh
Aug 31, 202636.1K sh
Latest fails to deliver
DateShares failed
Sep 23, 2026977 sh
Sep 16, 2026989 sh
Sep 15, 202685 sh
Sep 4, 2026651 sh
Sep 3, 2026201 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202670.4%
Nov 13, 202666.0%
Nov 12, 20264.2%
Nov 11, 20260.0%
Nov 10, 202621.1%
86-session median 24.1%mean 26.9%range 0.0–92.5%

130 calendar days requested; 87 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for CERO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 20,236 CERO shares were sold short (1.00 days to cover).